These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22766794)

  • 21. Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors.
    Salas S; Chibon F; Noguchi T; Terrier P; Ranchere-Vince D; Lagarde P; Benard J; Forget S; Blanchard C; Dômont J; Bonvalot S; Guillou L; Leroux A; Mechine-Neuville A; Schöffski P; Laë M; Collin F; Verola O; Carbonnelle A; Vescovo L; Bui B; Brouste V; Sobol H; Aurias A; Coindre JM
    Genes Chromosomes Cancer; 2010 Jun; 49(6):560-8. PubMed ID: 20232483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intra-abdominal desmoid fibromatosis mimicking tumour recurrence after the operation: A case series.
    Nam KH; Kim B
    Malays J Pathol; 2023 Apr; 45(1):111-122. PubMed ID: 37119251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review.
    Sakai T; Hamada S; Koike H; Shimizu K; Yoshida M; Nishida Y
    Jpn J Clin Oncol; 2020 Sep; 50(9):1037-1042. PubMed ID: 32533146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superficial fibromas with CTNNB1 mutation.
    Kuntze A; Meliß RR; Ermert L; Falkenberg KD; Puller AC; Trautmann M; Hartmann W; Wardelmann E
    Genes Chromosomes Cancer; 2024 May; 63(5):e23247. PubMed ID: 38757718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Approach to screening for Familial Adenomatous Polyposis (FAP) in a cohort of 226 patients with Desmoid-type Fibromatosis (DF): experience of a specialist center in the UK.
    Cojocaru E; Gennatas S; Thway K; Fisher C; Smrke A; Strauss D; Hayes A; Smith M; Jones RL; Benson C; McVeigh TP
    Fam Cancer; 2022 Jan; 21(1):69-74. PubMed ID: 33547536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fine-needle aspiration cytology and core needle biopsy in the preoperative diagnosis of desmoid tumors.
    Dalén BP; Meis-Kindblom JM; Sumathi VP; Ryd W; Kindblom LG
    Acta Orthop; 2006 Dec; 77(6):926-31. PubMed ID: 17260203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.
    Colombo C; Miceli R; Lazar AJ; Perrone F; Pollock RE; Le Cesne A; Hartgrink HH; Cleton-Jansen AM; Domont J; Bovée JV; Bonvalot S; Lev D; Gronchi A
    Cancer; 2013 Oct; 119(20):3696-702. PubMed ID: 23913621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the usefulness of nuclear beta-catenin in the diagnosis of desmoid-type fibromatosis among commonly used anti-beta-catenin antibodies.
    Yamada Y; Hirata M; Sakamoto A; Noguchi T; Ito K; Nishida Y; Matsuda S; Haga H
    Pathol Int; 2021 Jun; 71(6):392-399. PubMed ID: 33788979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple rapidly growing desmoid tumors that were difficult to distinguish from recurrence of rectal cancer.
    Nakanishi K; Shida D; Tsukamoto S; Ochiai H; Mazaki J; Taniguchi H; Kanemitsu Y
    World J Surg Oncol; 2017 Oct; 15(1):180. PubMed ID: 28974244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study.
    Koike H; Nishida Y; Kohno K; Shimoyama Y; Motoi T; Hamada S; Kawai A; Ogose A; Ozaki T; Kunisada T; Matsumoto Y; Matsunobu T; Ae K; Gokita T; Sakai T; Shimizu K; Ishiguro N
    Hum Pathol; 2019 Feb; 84():155-163. PubMed ID: 30292627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinicopathologic and genetic studies of desmoid-type fibromatosis].
    Yang JL; Wang J; Zhou XY; Li XQ; Hou YY; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2006 Mar; 35(3):145-50. PubMed ID: 16630502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical staining with non-phospho β-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosis.
    Sakai T; Nishida Y; Hamada S; Koike H; Ikuta K; Ota T; Ishiguro N
    Diagn Pathol; 2017 Aug; 12(1):66. PubMed ID: 28851389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions.
    Bhattacharya B; Dilworth HP; Iacobuzio-Donahue C; Ricci F; Weber K; Furlong MA; Fisher C; Montgomery E
    Am J Surg Pathol; 2005 May; 29(5):653-9. PubMed ID: 15832090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CTNNB1 Mutations and Estrogen Receptor Expression in Neuromuscular Choristoma and Its Associated Fibromatosis.
    Carter JM; Howe BM; Hawse JR; Giannini C; Spinner RJ; Fritchie KJ
    Am J Surg Pathol; 2016 Oct; 40(10):1368-74. PubMed ID: 27259010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical application of next-generation sequencing for the management of desmoid tumors: A case report and literature review.
    Lee JM; Kim HG; Shin SY; Lee SH
    Medicine (Baltimore); 2021 Jan; 100(1):e24238. PubMed ID: 33429825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinicopathological and molecular genetic features of neuromuscular choristoma-associated desmoid type fibromatosis].
    Dong RF; Guo W; Li N; Wang ZY; Sun XQ; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2024 Jul; 53(7):685-690. PubMed ID: 38955699
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk factors of local recurrence after surgery in extraabdominal desmoid-type fibromatosis: A multicenter study in Japan.
    Nishida Y; Hamada S; Kawai A; Kunisada T; Ogose A; Matsumoto Y; Ae K; Toguchida J; Ozaki T; Hirakawa A; Motoi T; Sakai T; Kobayashi E; Gokita T; Okamoto T; Matsunobu T; Shimizu K; Koike H
    Cancer Sci; 2020 Aug; 111(8):2935-2942. PubMed ID: 32539220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraabdominal sporadic desmoid tumors and inflammation: an updated literature review and presentation and insights on pathogenesis of synchronous sporadic mesenteric desmoid tumors occurring after surgery for necrotizing pancreatitis.
    Prete F; Rotelli M; Stella A; Calculli G; Sgaramella LI; Amati A; Resta N; Testini M; Gurrado A
    Clin Exp Med; 2023 Jul; 23(3):607-617. PubMed ID: 35913675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical characteristics of desmoid tumors.
    Dubova EA; Sidorenko TV; Shchyogolev AI; Adamyan AA
    Bull Exp Biol Med; 2012 Apr; 152(6):743-7. PubMed ID: 22803179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desmoid Fibromatosis With TP53 Mutation and Striking Nuclear Pleomorphism.
    Foster CR; Strauss M; Hornick JL; Habeeb O
    Int J Surg Pathol; 2023 Dec; 31(8):1565-1571. PubMed ID: 36908221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.